BlackRock Inc. - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 33 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$69,000
-53.1%
258,4190.0%0.00%
Q2 2022$147,000
-33.5%
258,419
-22.8%
0.00%
Q1 2022$221,000
-36.3%
334,675
+3.0%
0.00%
Q4 2021$347,000
-19.7%
325,043
-2.0%
0.00%
Q3 2021$432,000
-34.9%
331,773
-0.5%
0.00%
Q2 2021$664,000
-22.7%
333,405
+4.9%
0.00%
Q1 2021$859,000
-10.2%
317,8180.0%0.00%
Q4 2020$957,000
-38.5%
317,818
+1.2%
0.00%
Q3 2020$1,555,000
+77650.0%
314,126
+54247.1%
0.00%
Q2 2020$2,0005780.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders